Logotipo do repositório
 

Publicação:
Heterocyclic N-oxides -A promising class of agents against tuberculosis, malaria and neglected tropical diseases

dc.contributor.authorFernandes, Guilherme Felipe dos Santos [UNESP]
dc.contributor.authorPavan, Aline Renata [UNESP]
dc.contributor.authordos Santos, Jean Leandro [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T16:54:21Z
dc.date.available2018-12-11T16:54:21Z
dc.date.issued2018-01-01
dc.description.abstractHeterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000.en
dc.description.affiliationSão Paulo State University (UNESP) School of Pharmaceutical Sciences
dc.description.affiliationSão Paulo State University (UNESP) Institute of Chemistry
dc.description.affiliationUnespSão Paulo State University (UNESP) School of Pharmaceutical Sciences
dc.description.affiliationUnespSão Paulo State University (UNESP) Institute of Chemistry
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipIdFAPESP: 2015/19531-1
dc.description.sponsorshipIdFAPESP: 2015/21252-3
dc.description.sponsorshipIdFAPESP: 2016/09502-7
dc.format.extent1325-1340
dc.identifierhttp://dx.doi.org/10.2174/1381612824666180417122625
dc.identifier.citationCurrent Pharmaceutical Design, v. 24, n. 12, p. 1325-1340, 2018.
dc.identifier.doi10.2174/1381612824666180417122625
dc.identifier.issn1873-4286
dc.identifier.issn1381-6128
dc.identifier.scopus2-s2.0-85049665999
dc.identifier.urihttp://hdl.handle.net/11449/171198
dc.language.isoeng
dc.relation.ispartofCurrent Pharmaceutical Design
dc.relation.ispartofsjr0,883
dc.rights.accessRightsAcesso restritopt
dc.sourceScopus
dc.subjectChagas disease
dc.subjectDrug discovery
dc.subjectHeterocyclic N-oxides
dc.subjectLeishmaniasis
dc.subjectMalaria
dc.subjectN-oxide compounds
dc.subjectNeglected tropical diseases
dc.subjectTuberculosis
dc.titleHeterocyclic N-oxides -A promising class of agents against tuberculosis, malaria and neglected tropical diseasesen
dc.typeResenhapt
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Química, Araraquarapt

Arquivos